Aclaris Therapeutics, Inc. Compensation Agreements
11 Contracts & Agreements
- Ninth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 8, 2023)
- Eighth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 23, 2023)
- Seventh Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2022)
- Sixth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2022)
- Fifth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 5, 2021)
- Fourth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2021)
- Third Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2020)
- Second Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2020)
- Amended & Restated Non-Employee Director Compensation Policy (Filed With SEC on March 18, 2019)
- ACLARIS THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on September 25, 2015)
- ACLARIS THERAPEUTICS, INC. AMENDED AND RESTATED 2012 EQUITY COMPENSATION PLAN (Filed With SEC on September 4, 2015)
